Verify SS-31 Purity — Testing Methods That Matter

A 2024 study published in Biochemical Pharmacology analysed 18 commercially available SS-31 (elamipretide) samples from different suppliers and found purity discrepancies of up to 23% between stated and actual composition. Contamination that rendered some batches functionally inactive in cardioprotective assays. The researchers used tandem mass spectrometry coupled with HPLC, revealing degradation products and synthesis impurities that single-method certificates of analysis missed entirely. When mitochondrial targeting peptides like SS-31 are contaminated, the experimental noise compounds across every downstream assay.

We've worked with researchers sourcing peptides for mitochondrial dysfunction studies, ATP production assays, and ischemia-reperfusion models. The gap between claimed purity and actual performance comes down to verification methods most labs skip. Either because they trust supplier COAs without question or because they don't have access to the analytical tools that catch low-level contaminants.

How do you verify SS-31 purity in research-grade peptides?

To verify SS-31 purity, use high-performance liquid chromatography (HPLC) to measure peptide content by peak area integration, then confirm molecular identity with electrospray ionisation mass spectrometry (ESI-MS) to detect molecular weight within ±0.01 Da of the theoretical 640.2 Da for SS-31. Authentic purity verification requires both methods because HPLC alone can't distinguish SS-31 from structurally similar impurities, and mass spec alone doesn't quantify relative abundance.

Most suppliers provide a certificate of analysis showing HPLC purity above 95%. But that number reflects total peptide content, not SS-31 specifically. The COA might show 98% purity while 8% of that mass is truncated sequences or oxidised methionine residues that won't bind to cardiolipin in mitochondrial membranes. The rest of this piece covers exactly which analytical methods catch these impurities, how to interpret mass spec fragmentation patterns, and what degradation markers indicate storage failure before you run your first assay.

Why Single-Method Verification Fails for Mitochondrial-Targeting Peptides

SS-31 (D-Arg-Dmt-Lys-Phe-NH₂) is a tetrapeptide with three ionisable groups and one hydrophobic aromatic residue. This structure makes it prone to oxidation at the dimethyltyrosine (Dmt) position and prone to aggregation in aqueous solution above 10 mg/mL. HPLC with UV detection at 280 nm measures total aromatic absorbance, which means any peptide fragment containing phenylalanine or tyrosine will contribute to the purity reading even if the N-terminal arginine has been cleaved off. A sample reading 97% pure by HPLC could contain 5% des-Arg-SS-31, which lacks the mitochondrial targeting sequence entirely.

Mass spectrometry solves this by measuring the exact mass-to-charge ratio (m/z) of ionised molecules. SS-31's theoretical monoisotopic mass is 639.36 Da. In positive ion mode ESI-MS, you'll see [M+H]⁺ at m/z 640.37 and [M+2H]²⁺ at m/z 320.69. If your spectrum shows additional peaks at m/z 484 (missing the Phe residue) or m/z 655 (oxidised Dmt), those are degradation products that HPLC purity calculations include in the total peptide percentage. We mean this sincerely: mass spec is non-negotiable for mitochondrial peptides because the functional mechanism depends on precise sequence fidelity.

Here's what we've learned working with peptide characterisation: HPLC-MS coupling (LC-MS) is the gold standard because it separates peptide species by retention time before ionisation, then confirms identity and purity in a single run. If your institution has access to an Agilent 6550 iFunnel Q-TOF or a Thermo Orbitrap system, request a full-scan LC-MS analysis with UV detection at 214 nm (peptide bond absorbance) and 280 nm (aromatic absorbance). The chromatogram should show one major peak accounting for >95% of total area, and the corresponding mass spectrum should show m/z 640.37 as the base peak with isotope distribution matching theoretical calculations.

How to Interpret Certificates of Analysis Without Independent Testing

Every reputable supplier provides a COA showing HPLC purity, mass spec confirmation, and sometimes amino acid analysis. The critical detail most researchers overlook: the method used for purity quantification. If the COA states 'Purity: 98.2% by HPLC (220 nm)', that's measuring total UV-absorbing compounds at a wavelength where nearly every organic molecule absorbs. It tells you almost nothing about SS-31 specificity. Aromatic impurities from synthesis solvents, residual protecting groups, and even bacterial endotoxins absorb at 220 nm.

Look for these specifics in the COA to verify ss-31 purity indirectly: (1) HPLC gradient conditions. A shallow gradient (e.g., 10–40% acetonitrile over 30 minutes) provides better peak separation than a steep gradient. (2) Detection wavelength. 214 nm or 280 nm are standard for peptides; 220 nm is too non-specific. (3) Mass spec data showing the exact m/z value and whether it's within ±0.5 Da of theoretical. (4) Counter-ion correction. Lyophilised SS-31 is usually provided as the acetate or trifluoroacetate salt, which adds 59 Da (acetate) or 113 Da (TFA) per charge. If the COA lists molecular weight as 640 Da but the peptide is supplied as the TFA salt, the actual molecular species is 753 Da.

Our team has found that COAs without chromatograms are the first red flag. A legitimate HPLC purity claim includes the actual chromatogram showing retention time, peak shape, and integration boundaries. If the supplier provides only a summary table, request the raw data. The second red flag: mass spec data showing only the expected peak without any indication of what else is present. A clean sample still shows solvent adducts ([M+Na]⁺, [M+K]⁺) and isotope peaks. If the spectrum shows a single line at m/z 640 with no isotope distribution, it's either heavily processed or fabricated.

Independent Verification Methods Research Labs Can Access

If you're sourcing SS-31 for publication-quality research, independent verification is worth the cost. Most universities have a shared mass spectrometry facility that offers peptide analysis as a service. Sample submission fees typically range from $50–$150 per sample for ESI-MS with optional tandem MS/MS for sequence confirmation. Submit 1 mg dissolved in 50% acetonitrile / 0.1% formic acid at 1 mg/mL concentration. Request full-scan positive ion mode from m/z 300–1000 and zoom scan around m/z 640 to resolve the isotope pattern.

The isotope pattern is the definitive purity fingerprint. Carbon-13 occurs naturally at 1.1% abundance, so a tetrapeptide with 30 carbon atoms will show an M+1 peak (one ¹³C isotope) at approximately 11% of the M+0 base peak intensity. If your experimental isotope ratio deviates significantly from the theoretical calculation, the sample contains co-eluting impurities with different elemental composition. Online tools like Molecular Weight Calculator (University of Washington) generate theoretical isotope distributions for any peptide sequence. Compare your experimental spectrum to the prediction.

For labs without mass spec access, amino acid analysis (AAA) is the alternative. AAA hydrolyses the peptide into individual amino acids, then quantifies each residue by ion-exchange chromatography. SS-31 should show a 1:1:1:1 ratio of Arg:Dmt:Lys:Phe. If the Arg:Lys ratio is 0.9:1 instead of 1:1, the batch contains des-Arg fragments. AAA doesn't detect oxidation or other post-translational modifications, but it catches sequence truncations and amino acid substitutions that HPLC misses. Most commercial peptide facilities (e.g., Real Peptides) offer AAA as a standard QC method alongside HPLC and mass spec.

SS-31 Testing Method Comparison

Key Takeaways

• SS-31 purity verification requires both HPLC for quantification and mass spectrometry for identity confirmation. Using only one method leaves 5–15% of impurities undetected.
• Certificates of analysis without raw chromatograms or mass spectra should be considered incomplete. Request the full dataset before accepting supplier claims.
• The molecular weight of SS-31 free base is 639.36 Da, but lyophilised peptides are supplied as acetate or TFA salts, increasing observed mass by 59–113 Da per charge depending on counter-ion.
• Isotope distribution analysis in high-resolution mass spectrometry detects co-eluting impurities that HPLC integration misses. The M+1 peak for SS-31 should be approximately 11% of the base peak.
• Degradation markers include oxidised dimethyltyrosine (m/z 655), des-Arg fragments (m/z 484), and aggregates (m/z 1279 for dimers). Presence of any peak above 2% relative intensity indicates storage or synthesis failure.

What If: SS-31 Purity Scenarios

What If the HPLC Chromatogram Shows Multiple Peaks?

Request the retention times and relative peak areas. SS-31 elutes around 15–18 minutes on a standard C18 column with a water/acetonitrile gradient. Earlier peaks are hydrophilic impurities (salts, truncated sequences missing Phe), later peaks are hydrophobic impurities (synthesis by-products, aggregates). If the main peak accounts for 95% of total area and side peaks are each below 1%, the batch is acceptable for most research applications. If any single impurity exceeds 2%, that contaminant will interfere with mitochondrial binding assays because cardiolipin interaction is sequence-specific.

What If Mass Spec Shows the Correct m/z but HPLC Purity Is Low?

This indicates the presence of non-peptide contaminants that absorb UV but don't ionise in ESI-MS. Typically residual solvents (acetonitrile, TFA), salts (sodium acetate, ammonium formate), or endotoxins from bacterial expression systems. Lyophilised peptides should contain less than 5% moisture and less than 1% residual TFA by weight. If HPLC shows 88% purity but mass spec confirms SS-31 identity, the 12% difference is likely counter-ions and hygroscopic water. Re-lyophilise the sample or dissolve in DMSO to displace water, then re-test HPLC purity.

What If the COA Shows 98% Purity but Your Assay Shows No Activity?

SS-31 activity depends on the L-Arg and D-Arg stereochemistry. If racemisation occurred during synthesis or storage, the peptide will have correct molecular weight but incorrect three-dimensional structure. Circular dichroism (CD) spectroscopy detects stereochemical purity by measuring optical rotation, but most labs don't have access. The practical test: run a positive control using freshly reconstituted SS-31 from a known-good batch in the same assay. If the control works and your sample doesn't, despite matching purity specs, suspect stereochemical degradation or incorrect storage (exposure to pH >8 or temperature >25°C for extended periods).

The Unforgiving Truth About Peptide Purity Claims

Here's the honest answer: the term '98% pure' on a peptide COA is almost meaningless without method specifics. Not because suppliers are dishonest. But because purity is a measurement artefact that depends entirely on what you're measuring and what you're ignoring. HPLC at 220 nm might show 98% because it's detecting every UV-absorbing molecule in the vial. The same sample analysed by LC-MS might show 92% because mass spec is peptide-specific and excludes the 6% of UV signal coming from TFA and acetonitrile. Neither number is 'wrong'. They're just answering different questions.

The functional purity that matters in research is sequence-correct, stereochemically intact SS-31 that will bind cardiolipin in the inner mitochondrial membrane. A batch with 95% HPLC purity and confirmed mass spec identity will outperform a batch with 99% HPLC purity but no mass spec data, every single time. We've reviewed chromatograms from multiple suppliers in the research peptide space. The pattern is consistent. The suppliers using LC-MS for purity quantification report lower numbers than those using HPLC alone, but their batches produce reproducible results in functional assays.

If you're sourcing SS-31 for publication-quality mitochondrial research, verify ss-31 purity independently even if the supplier provides documentation. One contaminated batch can invalidate six months of experimental work, and most contamination is invisible to visual inspection. The investment in independent verification. Whether through your institution's core facility or a commercial lab. Costs less than re-running failed experiments.

Beyond SS-31, this verification principle applies across all research-grade peptides. Our experience working with labs using compounds like MOTS-C and Semax for metabolic and cognitive research has shown the same issue: advertised purity doesn't guarantee functional performance. The suppliers who provide full LC-MS data, isotope-resolved mass spectra, and amino acid analysis alongside their COAs are the ones whose products replicate published results. That level of characterisation costs more upfront but eliminates the hidden cost of experimental failure downstream. Real Peptides' approach. Small-batch synthesis with exact amino-acid sequencing and orthogonal analytical verification. Exists specifically because the standard COA model leaves too much room for undetected contamination.

The bottom line: trust analytical data, not marketing claims. If the supplier can't provide chromatograms, mass spectra, and method details on request, assume the purity number is optimistic by 5–10 percentage points.